Recent publications
Article
Weigand, I, Ronchi, C, Vanselow, JT, Bathon, K, Lenz, K, Herterich, S, Schlosser, A, Kroiss, M, Fassnacht, M, Calebiro, D & Sbiera, S 2021, 'PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser114 phosphorylation', Science Advances, vol. 7, no. 8, eabd4176. https://doi.org/10.1126/sciadv.abd4176
Majidi, F, Martino, S, Kondakci, M, Antke, C, Haase, M, Chortis, V, Arlt, W, Ronchi, C, Fassnacht, M, Laurent, C, Petit, J-M, Casasnovas, O, Habra, M, Kanji, A, Salvatori, R, Ho, ATN, Spyroglou, A, Beuschlein, F, Villa, D, Limvorapitak, W, Engelbrekt Wahlin, B, Gimm, O, Rudelius, M, Schott, M, Germing, U, Haas, R & Gattermann, N 2020, 'Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study', European Journal of Endocrinology, vol. 183, no. 4, pp. 453–462. https://doi.org/10.1530/EJE-19-0506
Altieri, B, Sbiera, S, Herterich, S, De Francia, S, Della Casa, S, Calabrese, A, Pontecorvi, A, Quinkler, M, Kienitz, T, Mannelli, M, Canu, L, Angelousi, A, Chortis, V, Kroiss, M, Terzolo, M, Fassnacht, M & Ronchi, CL 2020, 'Effects of germline CYP2W1*6 and CYP2B6*6 single nucleotide polymorphisms on mitotane treatment in adrenocortical carcinoma: a multicenter ENSAT study', Cancers, vol. 12, no. 2, 359. https://doi.org/10.3390/cancers12020359, https://doi.org/10.3390/cancers12020359
Weigand, I, Altieri, B, Lacombe, A, Basile, V, Kircher, S, Landwehr, L-S, Schreiner, J, Zerbini, M, Ronchi, C, Megerle, F, Berruti, A, Canu, L, Volante, M, Paiva, I, Della Casa, S, Sbiera, S, Fassnacht, M, Fragoso, M, Terzolo, M & Kroiss, M 2020, 'Expression of SOAT1 in adrenocortical carcinoma and response to mitotane monotherapy: an ENSAT multicenter study', The Journal of clinical endocrinology and metabolism. https://doi.org/10.1210/clinem/dgaa293
Drougat, L, Settas, N, Ronchi, C, Bathon, K, Calebiro, D, Gutierrez, A, Haydar, S, Voutetakis, A, London, E, Faucz, FR & Stratakis, C 2020, 'Genomic and sequence variants of protein kinase A regulatory subunit type 1β (PRKAR1B) in patients with adrenocortical disease and Cushing syndrome', Genetics in Medicine. https://doi.org/10.1038/s41436-020-00958-1
Chifu, I, Heinze, B, Fuss, C, Lang, K, Kroiss, M, Kircher, S, Ronchi, C, Altieri, B, Schirbel, A, Fassnacht, M & Hahner, S 2020, 'Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma', Frontiers in Endocrinology.
Jouinot, A, Lippert, J, Fassnacht, M, De La Villeon, B, Septier, A, Neou, M, Perlemoine, K, Appenzeller, S, Sibony, M, Gaujoux, S, Dousset, B, Libe, R, Groussin, L, Ronchi, C, Assie', G & Bertherat, J 2020, 'Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma', Endocrine Connections. https://doi.org/10.1530/EC-20-0228
Altieri, B, Ronchi, C, Kroiss, M & Fassnacht, M 2020, 'Next-generation therapies for adrenocortical carcinoma', Best practice & research. Clinical endocrinology & metabolism. https://doi.org/10.1016/j.beem.2020.101434
Dalmazi, GD, Altieri, B, Scholz, C, Sbiera, S, Luconi, M, Waldmann, J, Kastelan, D, Ceccato, F, Chiodini, I, Arnaldi, G, Riester, A, Osswald, A, Beuschlein, F, Sauer, S, Fassnacht, M, Appenzeller, S & Ronchi, C 2020, 'RNA-sequencing and somatic mutation status of adrenocortical tumors: novel pathogenetic insights', Journal of Clinical Endocrinology and Metabolism, vol. 105, no. 12, pp. e4459–e4473. https://doi.org/10.1210/clinem/dgaa616
Creemers, SG, Feelders, RA, Valdes, N, Ronchi, C, Volante, M, Van Hemel, BM, Luconi, M, Ettaieb, MHT, Mannelli, M, Chiara, MD, Fassnacht, M, Papotti, M, Kerstens, MN, Nesi, G, Haak, HR, Van Kemenade, FJ & Hofland, LJ 2020, 'THE IGF2 METHYLATION SCORE FOR ADRENOCORTICAL CANCER: AN ENSAT VALIDATION STUDY', Endocrine-related cancer.
Liang, R, Weigand, I, Lippert, J, Kircher, S, Altieri, B, Steinhauer, S, Hantel, C, Rost, S, Rosenwald, A, Kroiss, M, Fassnacht, M, Sbiera, S & Ronchi, C 2020, 'Targeted gene expression profile reveals CDK4 as therapeutic target for selected patients with adrenocortical carcinoma', Frontiers in Endocrinology, vol. 11, 219. https://doi.org/10.3389/fendo.2020.00219
Chortis, V, Bancos, I, Nijman, T, Gilligan, L, Taylor, A, Ronchi, C, O'Reilly, M, Schreiner, J, Asia, M, Riester, A, Perotti, P, Libe, R, Quinkler, M, Canu, L, Paiva, I, Bugalho, MJ, Kastelan, D, Dennedy, MC, Sherlock, M, Ambroziak, U, Vassiliadi, D, Bertherat, J, Beuschlein, F, Fassnacht, M, Deeks, J, Biehl, M & Arlt, W 2020, 'Urine steroid metabolomics as a novel tool for detection of recurrent adrenocortical carcinoma', Journal of Clinical Endocrinology and Metabolism, vol. 105, no. 3, pp. e303–e314. https://doi.org/10.1210/clinem/dgz141
ENSAT EURINE-ACT Investigators 2020, 'Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study', The Lancet Diabetes and Endocrinology, vol. 8, no. 9, pp. 773-781. https://doi.org/10.1016/S2213-8587(20)30218-7
Bathon, K, Wigand, I, Vanselow, JT, Ronchi, C, Sbiera, S, Schlosser, A, Calebiro, D & Fassnacht, M 2019, 'Alterations in protein kinase A substrate specificity as a potential cause of Cushing’s Syndrome', Endocrinology, vol. 160, no. 2, pp. 447-459. https://doi.org/10.1210/en.2018-00775
Review article
Crona, J & Ronchi, C 2020, 'ENSAT registry-based randomized clinical trials for adrenocortical carcinoma', European Journal of Endocrinology. https://doi.org/10.1530/EJE-20-0800
View all publications in research portal